MedPath

The investigation of the effectiveness by tofogliflozin on macular edema among the Japanese patients with type 2 diabetes mellitus

Not Applicable
Recruiting
Conditions
Macular edema
Registration Number
JPRN-UMIN000029609
Lead Sponsor
Ehime University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

History of severe hypoglycemia Cerebral infaction with paralysis Repeated genital infection and urinary tract infection Type 1 diabetes mellitus Patients with cancer during treatment(excluding no recurrence of cancer) Aspartate aminotransferase(AST)or alanine transaminase(ALT) 100 IU/L or more Patients in need of anti-VEGF therapy for diabetic macular edema Patients in need of pan retinal photocoagulation for diabetic macular edema Patients with vitreomacular traction observed with OCT

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The change of CRT at 52 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath